Market Research Logo

Coronary Stents Market: Global Industry Analysis and Opportunity Assessment 2016-2026

Coronary Stents Market: Global Industry Analysis and Opportunity Assessment 2016-2026

A coronary stent is a small cylindrical device used during percutaneous coronary intervention (PCI). Coronary stents help relieve the symptoms of coronary heart disease by reducing blockages and improving blood flow to the heart. They are beneficial for patients suffering from coronary artery diseases such as myocardial infarction and unstable angina. The global coronary stents market is estimated to be valued at US$ 11.32 Bn by 2026, registering a CAGR of 6.6% over the forecast period.

Increasing prevalence of cardiovascular diseases expected to drive overall market growth

The global coronary stents market is driven by an increasing occurrence of lifestyle diseases such as obesity and cardiovascular diseases such as angina pectoris and ischemic heart disease especially in developed countries. Also, an increasing meditech progress in the cardiovascular field is expected to drive the growth of the global coronary stents market during the forecast period. Cardiologists the world over prefer advanced stenting procedures and this is another important factor boosting market growth. However, various complications and risks associated with stenting procedures and high costs of drug eluting stents is expected to adversely affect the revenue growth of the global coronary stents market over the forecast period.

Market segmentation

By Product Type

By Raw Material

By End Use

By Region

Drug Eluting Stent

Bare Metal Stent

Bioresorbable Vascular Stent

Cobalt Chromium

Stainless Steel

Platinum-Chromium

Nickel-Titanium

Polymer

Hospitals

Ambulatory Surgical Centres

Cardiac Catheterisation Laboratories

North America

Latin America

Western Europe

Eastern Europe

APEJ

MEA

Japan

Drug Eluting Stent product type segment estimated to account for significant market share by 2016 end

The Drug Eluting Stent segment is anticipated to account for 75.6% value share of the global coronary stents market by the end of 2016. This segment is expected to register a CAGR of 6.8% in terms of value over the forecast period. The Bioresorbable Vascular Stent segment is projected to register a CAGR of 9.4% between 2016 and 2026 and reach a market valuation of US$ 1,617.6 Mn by 2026.

Polymer raw material segment likely to be the most lucrative segment

The Polymer segment is expected to register high Y-o-Y growth throughout the forecast period and is expected to be valued at US$ 4,215.6 Mn by 2026, registering a CAGR of 9.2% during the forecast period. The Cobalt Chromium segment is estimated to account for 21.4% market share of the global coronary stents market by the end of 2016.

Hospitals end use segment expected to dominate the global coronary stents market in terms of value

The Hospitals segment is estimated to be valued at US$ 7,851.8 Mn by 2026, registering a CAGR of 6.3% during the forecast period. The Cardiac Catheterisation Laboratories segment is estimated to account for 19.8% revenue share by 2016 end.

APEJ market likely to register significant Y-o-Y growth throughout the forecast period

The APEJ coronary stents market is expected to hold 36.8% revenue share of the global coronary stents market by 2026. The APEJ market is expected to witness a CAGR of 8.0% during the forecast period. The North America market is anticipated to account for 29.2% market share of the global coronary stents market by 2016 end. Revenue from the North America market is projected to register a CAGR of 6.9% during 2016–2026, to reach a market valuation of US$ 3,426.0 Mn by 2026.

coronary stents market

Global coronary stents market players are focussing on product innovation and geographical expansion to augment market share

Terumo Corporation, Boston Scientific Corporation, Medtronic, Vascular Concepts, B. Braun Melsungen AG, Biotronik SE & Co. KG, Abbott Laboratories, Biosensors International Group, Ltd., Hexacath, and Stentys SA are some of the top companies operating in the global coronary stents market. Key market players are focussing on increasing their footprints in emerging markets such as Asia Pacific and are expanding their manufacturing facilities and distribution network to gain a larger share of the global coronary stents market.

Abbott Laboratories, Medtronic, and Boston Scientific Corporation emerged as the market leaders in the global coronary stents market for both the Drug Eluting Stent and Bare Metal Stent segments in 2015. The top three market players are estimated to hold more than 70% revenue share of the global coronary stents market in 2016. Abbott Laboratories accounted for the largest share in the global coronary stents market in 2015. Boston Scientific Corporation held maximum revenue share in Brazil in 2015. The company has a strong foothold in the domestic market of Latin America, particularly in the rapidly growing cardiovascular devices market in Brazil and other emerging countries.


1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Coronary Stents Market Introduction
4.1. Market Definition
4.2. Market Taxonomy
5. Coronary Stents Market Analysis Scenario
5.1. Coronary Stents Market Size (US$ Mn) and Forecast
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Coronary Stents Market Overview
5.2.1. Value Chain
5.2.2. Epidemiology of Cardiovascular Diseases
5.2.3. Key Regulations and Reimbursement Scenario
5.2.4. PEST Analysis
6. Coronary Stents Market Dynamics
6.1. Macro-economic Factors
6.2. Drivers
6.2.1. Supply Side
6.2.2. Demand Side
6.3. Restraints
6.4. Opportunity
6.5. Trends
7. Global Coronary Stents Market Analysis and Forecast, By Product
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis By Product
7.1.2. Y-o-Y Growth Projections By Product
7.2. Market Size (US$ Mn) and Volume (Units) Forecast By Product
7.2.1. Drug Eluting Stent (DES)
7.2.2. Bare Metal Stent (BMS)
7.2.3. Bioresorbable Vascular Stent (BVS)
7.3. Global Coronary Stents Market Attractiveness Analysis, By Product Type
8. Global Coronary Stents Market Analysis and Forecast, By Raw Material
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Raw Material
8.1.2. Y-o-Y Growth Projections By Raw Material
8.2. Market Size (US$ Mn) Forecast By Raw Material
8.2.1. Cobalt Chromium
8.2.2. Stainless Steel
8.2.3. Platinum – Chromium
8.2.4. Nickel – Titanium
8.2.5. Polymer
8.3. Global Coronary Stents Market Attractiveness Analysis, By Raw Material
9. Global Coronary Stents Market Analysis and Forecast, By End User
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By End User
9.1.2. Y-o-Y Growth Projections By End User
9.2. Market Size (US$ Mn) Forecast By End User
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
9.2.3. Cardiac Catheterization Laboratories
9.3. Market Attractiveness Analysis By End User
10. Global Coronary Stents Market Analysis and Forecast, By Region
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Region
10.1.2. Y-o-Y Growth Projections By Region
10.2. Market Size (US$ Mn) Forecast By Region
10.2.1. North America
10.2.2. Latin America
10.2.3. Brazil
10.2.4. Western Europe
10.2.5. Eastern Europe
10.2.6. Asia Pacific Excluding Japan
10.2.7. Japan
10.2.8. Middle East and Africa (MEA)
10.3. Market Attractiveness Analysis By Region
11. North America Coronary Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Size (US$ Mn) Forecast By Country
11.2.1. U.S.
11.2.2. Canada
11.3. Market Size (US$ Mn) Forecast By Product
11.3.1. Drug Eluting Stent (DES)
11.3.2. Bare Metal Stent (BMS)
11.3.3. Bioresorbable Vascular Stent (BVS)
11.4. Market Size (US$ Mn) Forecast By Raw Material
11.4.1. Cobalt Chromium
11.4.2. Stainless Steel
11.4.3. Platinum – Chromium
11.4.4. Nickel – Titanium
11.4.5. Polymer
11.5. Market Size (US$ Mn) Forecast By End User
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Cardiac Catheterization Laboratories
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Product
11.6.3. By Raw Material
11.6.4. By End User
11.7. Prominent Trends
11.8. Drivers and Restraints: Impact Analysis
12. Latin America Coronary Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country
12.2.1. Mexico
12.2.2. Argentina
12.2.3. Rest of Latin America
12.3. Market Size (US$ Mn) Forecast By Product
12.3.1. Drug Eluting Stent (DES)
12.3.2. Bare Metal Stent (BMS)
12.3.3. Bioresorbable Vascular Stent (BVS)
12.4. Market Size (US$ Mn) Forecast By Raw Material
12.4.1. Cobalt Chromium
12.4.2. Stainless Steel
12.4.3. Platinum – Chromium
12.4.4. Nickel – Titanium
12.4.5. Polymer
12.5. Market Size (US$ Mn) Forecast By End User
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Cardiac Catheterization Laboratories
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Product
12.6.3. By Raw Material
12.6.4. By End User
12.7. Prominent Trends
12.8. Drivers and Restraints: Impact Analysis
13. Brazil Coronary Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2. Market Size (US$ Mn) Forecast By Product
13.2.1. Drug Eluting Stent (DES)
13.2.2. Bare Metal Stent (BMS)
13.2.3. Bioresorbable Vascular Stent (BVS)
13.3. Market Size (US$ Mn) Forecast By Raw Material
13.3.1. Cobalt Chromium
13.3.2. Stainless Steel
13.3.3. Platinum – Chromium
13.3.4. Nickel – Titanium
13.3.5. Polymer
13.4. Market Size (US$ Mn) Forecast By End User
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Cardiac Catheterization Laboratories
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Raw Material
13.5.3. By End User
14. Western Europe Coronary Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country / Region
14.1.2. Y-o-Y Growth Projections By Country
14.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country / Region
14.2.1. Germany
14.2.2. France
14.2.3. Italy
14.2.4. Spain
14.2.5. U.K.
14.2.6. BENELUX
14.2.7. Rest of Western Europe
14.3. Market Size (US$ Mn) Forecast By Product
14.3.1. Drug Eluting Stent (DES)
14.3.2. Bare Metal Stent (BMS)
14.3.3. Bioresorbable Vascular Stent (BVS)
14.4. Market Size (US$ Mn) Forecast By Raw Material
14.4.1. Cobalt Chromium
14.4.2. Stainless Steel
14.4.3. Platinum – Chromium
14.4.4. Nickel – Titanium
14.4.5. Polymer
14.5. Market Size (US$ Mn) Forecast By End User
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Cardiac Catheterization Laboratories
14.6. Market Attractiveness Analysis
14.6.1. By Country
14.6.2. By Product
14.6.3. By Raw Material
14.6.4. By End User
14.7. Prominent Trends
14.8. Drivers and Restraints: Impact Analysis
15. Eastern Europe Coronary Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country
15.2.1. Russia
15.2.2. Poland
15.2.3. Rest of Eastern Europe
15.3. Market Size (US$ Mn) Forecast By Product
15.3.1. Drug Eluting Stent (DES)
15.3.2. Bare Metal Stent (BMS)
15.3.3. Bioresorbable Vascular Stent (BVS)
15.4. Market Size (US$ Mn) Forecast By Raw Material
15.4.1. Cobalt Chromium
15.4.2. Stainless Steel
15.4.3. Platinum – Chromium
15.4.4. Nickel – Titanium
15.4.5. Polymer
15.5. Market Size (US$ Mn) Forecast By End User
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Cardiac Catheterization Laboratories
15.6. Market Attractiveness Analysis
15.6.1. By Country
15.6.2. By Product
15.6.3. By Raw Material
15.6.4. By End User
15.7. Prominent Trends
15.8. Drivers and Restraints: Impact Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report